相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study
Huib A M Kerstjens et al.
Lancet Respiratory Medicine (2020)
A randomized, double-blind study to compare the efficacy and safety of two doses of mometasone furoate delivered via Breezhaler® or Twisthaler® in patients with asthma
Roland Buhl et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2020)
Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD
Yasushi Fukushima et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well-Controlled Asthma
Andy Fowler et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Japanese guidelines for adult asthma 2017
Masakazu Ichinose et al.
ALLERGOLOGY INTERNATIONAL (2017)
Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study
Jadwiga A. Wedzicha et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
Mometasone Furoate (MF) Improves Lung Function in Pediatric Asthma: A Dose-Ranging Study of MF Metered-Dose Inhaler (MDI)
Niran J. Amar et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Pharmacokinetics of indacaterol and mometasone furoate delivered alone or in a free or fixed dose combination in healthy subjects
Soniya S. Vaidya et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2016)
Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study
Shu Hashimoto et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2016)
Pharmacokinetics of QMF149 in Japanese versus Caucasian subjects: an open-label, randomized phase I study
Sayaka Shimada et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2015)
Once-daily glycopyrronium via the Breezhaler® device for the treatment of COPD: pharmacological and clinical profile
Mathieu Molimard et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2013)
Global asthma prevalence in adults: findings from the cross-sectional world health survey
Teresa To et al.
BMC PUBLIC HEALTH (2012)
Systemic pharmacokinetics of indacaterol, an inhaled once-daily long-acting β2-agonist, in different ethnic populations
Soichiro Matsushima et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2012)
Pharmacokinetics of multiple inhaled NVA237 doses in patients with chronic obstructive pulmonary disease (COPD)
Romain Sechaud et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2012)
Modeling the Impact of Increased Adherence to Asthma Therapy
Amory Schlender et al.
PLOS ONE (2012)
Efficacy, Safety and Pharmacokinetics of Indacaterol in Caucasian and Japanese Patients with Chronic Obstructive Pulmonary Disease A Comparison of Data from Two Randomized, Placebo-Controlled Studies
Motoi Hosoe et al.
CLINICAL DRUG INVESTIGATION (2011)
Efficacy, safety, and tolerability of mometasone furoate in adult Japanese patients with mild asthma: open-label clinical trial findings
Yuji Tohda et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
24-h bronchodilator efficacy of single doses of indacaterol in Japanese patients with asthma: A comparison with placebo and salmeterol
Naruhiko Sugihara et al.
RESPIRATORY MEDICINE (2010)
Bronchodilator Efficacy of Single Doses of Indacaterol in Japanese Patients with COPD: A Randomised, Double-Blind, Placebo-Controlled Trial
Motokazu Kato et al.
ALLERGOLOGY INTERNATIONAL (2010)
The role of ethnicity in variability in response to drugs: Focus on clinical pharmacology studies
S. U. Yasuda et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: Comparison with Korean, Chinese, and Caucasian populations
S. P. Myrand et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
One-year treatment with mometasone furoate in chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
RESPIRATORY RESEARCH (2008)
Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study
C. LaForce et al.
ALLERGY (2008)
Safety and tolerability of indacaterol in asthma: A randomized, placebo-controlled 28-day study
Alexander G. Chuchalin et al.
RESPIRATORY MEDICINE (2007)
Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies
SW Stoloff et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses
MB Affrime et al.
CHEST (2000)
分享论文
